In an alarming story, the manufacturer of over-the-counter children’s medications has agreed to plead guilty to federal charges that it sold dangerous products that contained metal particles.
According to the Associated Press, through a settlement, McNeil Consumer Healthcare, of Fort Washington, Pennsylvania, will acknowledge that it sold adulterated bottles of Infants’ and Children’s Tylenol and Children’s Motrin. It has also agreed to pay a $25 million fine.
The products reportedly contained nickel, iron and chromium, which were introduced during the manufacturing process, according to the AP. The prosecutors working on the case said the company did not take immediate steps to fix the issue, taking nearly a year to resolve it.
According to court documents, McNeil learned about the problems in May 2009, but continued to manufacturer medications in the same process for several months.
Eventually, the company issued a recall. It should be noted that McNeil is a unit of Johnson & Johnson.
Speaking to an Attorney about a Dangerous Drug
This case is shocking. Due to negligence during the manufacturing process, the Food and Drug Administration had to issue a notice to consumers to stop using the medications. Remember, manufacturers, including over-the-counter drug makers, have an obligation to provide a safe product to customers. Those who do not should be held accountable.
Defective drugs can lead to grave medical conditions, requiring extensive and ongoing medical treatment. In this particular case, those injured by the products could have included children. This is unacceptable.
If a defective drug has injured you or a loved one, it may be wise to speak to an attorney. Your case will need to be investigated by someone who knows the law thoroughly when it comes to manufacturer liability. For more information about how we have helped victims of defective products, visit our verdicts and settlements page.
Targan Pender & Strickland, P.C. – Atlantic City Injury Attorneys
Targan Talk: There were more than 100 Class I pharmaceutical drug recalls in 2014, according to the FDA.